Chemokine-chemokine receptor axes in melanoma brain metastasis

Immunology Letters

Volumn 130, Issue 1-2, 2010, Pages 107-114

  Izraely, Sivan ^a   Klein, Anat ^a   Sagi Assif, Orit ^a   Meshel, Tsipi ^a   Tsarfaty, Galia ^b   Hoon, Dave S B ^c   Witz, Isaac P ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Brain metastasis; CCL22; CCR4; Chemokine receptor expression by melanoma; Chemokine receptors; Chemokines; Melanoma

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR7; FRACTALKINE; MACROPHAGE DERIVED CHEMOKINE; PROTEIN KINASE B; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; CANCER CELL CULTURE; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIGAND BINDING; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR BIOPSY; TUMOR XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHEMOKINE CCL17; CHEMOKINE CCL22; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; RECEPTORS, CHEMOKINE; SKIN NEOPLASMS;

EID: 77950942116     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.12.003     Document Type: Article

References (27)

1. Fidler I.J., Schackert G., Zhang R.D., Radinsky R., Fujimaki T. The biology of melanoma brain metastasis. Cancer Metastasis Rev 1999, 18:387-400.
2. Bafaloukos D., Gogas H. The treatment of brain metastases in melanoma patients. Cancer Treat Rev 2004, 30:515-520.
3. Bruns C.J., Harbison M.T., Kuniyasu H., Eue I., Fidler I.J. In vivo selection characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia 1999, 1:50-62.
4. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:453-458.
5. Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 2008, 25:345-356.
6. Seidl H., Richtig E., Tilz H., Stefan M., Schmidbauer U., Asslaber M., et al. Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Hum Pathol 2007, 38:768-780.
7. Murakami T., Cardones A.R., Hwang S.T. Chemokine receptors and melanoma metastasis. J Dermatol Sci 2004, 36:71-78.
8. Kim J., Mori T., Chen S.L., Amersi F.F., Martinez S.R., Kuo C., et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg 2006, 244:113-120.
9. Mori T., Kim J., Yamano T., Takeuchi H., Huang S., Umetani N., et al. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Res 2005, 65:1800-1807.
10. Bajetto A., Bonavia R., Barbero S., Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 2002, 82:1311-1329.
11. Berger W., Elbling L., Minai-Pour M., Vetterlein M., Pirker R., Kokoschka E.M., et al. Intrinsic MDR-1 gene and P-glycoprotein expression in human melanoma cell lines. Int J Cancer 1994, 59:717-723.
12. de Haas A.H., van Weering H.R., de Jong E.K., Boddeke H.W., Biber K.P. Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol 2007, 36:137-151.
13. Okada N., Gao J.Q., Sasaki A., Niwa M., Okada Y., Nakayama T., et al. Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy. Biochem Biophys Res Commun 2004, 317:68-76.
14. Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 2006, 25:357-371.
15. Ishida T., Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 2006, 97:1139-1146.
16. Raman D., Baugher P.J., Thu Y.M., Richmond A. Role of chemokines in tumor growth. Cancer Lett 2007, 256:137-165.
17. Geminder H., Sagi-Assif O., Goldberg L., Meshel T., Rechavi G., Witz I.P., et al. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001, 167:4747-4757.
18. Goldberg-Bittman L., Sagi-Assif O., Meshel T., Nevo I., Levy-Nissenbaum O., Yron I., et al. Cellular characteristics of neuroblastoma cells: regulation by the ELR-CXC chemokine CXCL10 and expression of a CXCR3-like receptor. Cytokine 2005, 29:105-117.
19. Nevo I., Sagi-Assif O., Meshel T., Ben-Baruch A., Johrer K., Greil R., et al. The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells. Cancer Lett 2009, 273:127-139.
20. Zipin-Roitman A., Meshel T., Sagi-Assif O., Shalmon B., Avivi C., Pfeffer R.M., et al. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 2007, 67:3396-3405.
21. Neumark E., Sagi-Assif O., Shalmon B., Ben-Baruch A., Witz I.P. Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors. Int J Cancer 2003, 106:879-886.
22. Witz I.P. Yin-yang activities and vicious cycles in the tumor microenvironment. Cancer Res 2008, 68:9-13.
23. Nevo I., Sagi-Assif O., Meshel T., Geminder H., Goldberg-Bittman L., Ben-Menachem S., et al. The tumor microenvironment: CXCR4 is associated with distinct protein expression patterns in neuroblastoma cells. Immunol Lett 2004, 92:163-169.
24. Robledo M.M., Bartolome R.A., Longo N., Rodriguez-Frade J.M., Mellado M., Longo I., et al. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 2001, 276:45098-45105.
25. Russo A.E., Torrisi E., Bevelacqua Y., Perrotta R., Libra M., McCubrey J.A., et al. Melanoma: molecular pathogenesis and emerging target therapies (review). Int J Oncol 2009, 34:1481-1489.
26. Takeuchi H., Kim J., Fujimoto A., Umetani N., Mori T., Bilchik A., et al. X-linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling. Clin Cancer Res 2005, 11:7621-7628.
27. Zhang W., Tsan R., Nam D.H., Lu W., Fidler I.J. Loss of adhesion in the circulation converts amelanotic metastatic melanoma cells to melanotic by inhibition of AKT. Neoplasia 2006, 8:543-550.